Literature DB >> 18182498

Nogo receptor antagonizes p75NTR-dependent motor neuron death.

Luc Dupuis1, Mariana Pehar, Patricia Cassina, Frédérique Rene, Raquel Castellanos, Caroline Rouaux, Mandi Gandelman, Leda Dimou, Martin E Schwab, Jean-Philippe Loeffler, Luis Barbeito, Jose-Luis Gonzalez de Aguilar.   

Abstract

The Nogo-66 receptor (NgR) plays a critical role in restricting axon regeneration in the central nervous system. This inhibitory action is in part mediated by a neuronal receptor complex containing p75NTR, a multifunctional receptor also well known to trigger cell death upon binding to neurotrophins such as NGF. In the present study, we show that Pep4 and NEP1-40, which are two peptides derived from the Nogo-66 sequence that modulate NgR-mediated neurite outgrowth inhibition, prevent NGF-stimulated p75NTR-dependent death of cultured embryonic motor neurons. They also confer protection on spinal cord motor neurons after neonatal sciatic nerve axotomy. These findings demonstrate an as-yet-unknown function of NgR in maintaining neuronal survival that may be relevant for motor neuron development and degeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182498      PMCID: PMC2206606          DOI: 10.1073/pnas.0703842105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  p75NTR--live or let die.

Authors:  Anders Nykjaer; Thomas E Willnow; Claus Munck Petersen
Journal:  Curr Opin Neurobiol       Date:  2005-02       Impact factor: 6.627

2.  The role of p75NTR in modulating neurotrophin survival effects in developing motoneurons.

Authors:  S Wiese; F Metzger; B Holtmann; M Sendtner
Journal:  Eur J Neurosci       Date:  1999-05       Impact factor: 3.386

3.  Astrocyte activation by fibroblast growth factor-1 and motor neuron apoptosis: implications for amyotrophic lateral sclerosis.

Authors:  Patricia Cassina; Mariana Pehar; Marcelo R Vargas; Raquel Castellanos; Ana G Barbeito; Alvaro G Estévez; John A Thompson; Joseph S Beckman; Luis Barbeito
Journal:  J Neurochem       Date:  2005-04       Impact factor: 5.372

4.  Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.

Authors:  Ji-Eun Kim; Betty P Liu; James H Park; Stephen M Strittmatter
Journal:  Neuron       Date:  2004-10-28       Impact factor: 17.173

5.  A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors.

Authors:  Jong Bae Park; Glenn Yiu; Shinjiro Kaneko; Jing Wang; Jufang Chang; Xiaolin L He; K Christopher Garcia; Zhigang He
Journal:  Neuron       Date:  2005-02-03       Impact factor: 17.173

6.  TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.

Authors:  Zhaohui Shao; Jeffrey L Browning; Xinhua Lee; Martin L Scott; Sveltlana Shulga-Morskaya; Norm Allaire; Greg Thill; Melissa Levesque; Dinah Sah; John M McCoy; Beth Murray; Vincent Jung; R Blake Pepinsky; Sha Mi
Journal:  Neuron       Date:  2005-02-03       Impact factor: 17.173

7.  Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.

Authors:  Binhai Zheng; Jasvinder Atwal; Carole Ho; Lauren Case; Xiao-lin He; K Christopher Garcia; Oswald Steward; Marc Tessier-Lavigne
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

8.  Expression pattern of NOGO and NgR genes during human development.

Authors:  Hassan Al Halabiah; Anne-Lise Delezoide; Ana Cardona; Jean-Marie Moalic; Michel Simonneau
Journal:  Gene Expr Patterns       Date:  2005-04       Impact factor: 1.224

9.  Promotion of axon regeneration by myelin-associated glycoprotein and Nogo through divergent signals downstream of Gi/G.

Authors:  Yuiko Hasegawa; Masashi Fujitani; Katsuhiko Hata; Masaya Tohyama; Satoru Yamagishi; Toshihide Yamashita
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

10.  Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.

Authors:  Shuxin Li; Betty P Liu; Stephane Budel; Mingwei Li; Benxiu Ji; Lee Walus; Weiwei Li; Adrienna Jirik; Sylvia Rabacchi; Eugene Choi; Dane Worley; Dinah W Y Sah; Blake Pepinsky; Daniel Lee; Jane Relton; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2004-11-17       Impact factor: 6.167

View more
  12 in total

1.  The in vivo contribution of motor neuron TrkB receptors to mutant SOD1 motor neuron disease.

Authors:  Jinbin Zhai; Weiguo Zhou; Jian Li; Christopher R Hayworth; Lei Zhang; Hidemi Misawa; Rudiger Klein; Steven S Scherer; Rita J Balice-Gordon; Robert Gordon Kalb
Journal:  Hum Mol Genet       Date:  2011-08-04       Impact factor: 6.150

2.  Amino-Nogo-A antagonizes reactive oxygen species generation and protects immature primary cortical neurons from oxidative toxicity.

Authors:  Y-J Mi; B Hou; Q-M Liao; Y Ma; Q Luo; Y-K Dai; G Ju; W-L Jin
Journal:  Cell Death Differ       Date:  2012-01-20       Impact factor: 15.828

3.  Expression of Wnt5a and its receptor Fzd2 is changed in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice.

Authors:  Xiaojin Li; Yingjun Guan; Yanchun Chen; Caixia Zhang; Caixing Shi; Fenghua Zhou; Li Yu; Juan Juan; Xin Wang
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

4.  Aptamer antagonists of myelin-derived inhibitors promote axon growth.

Authors:  Yuxuan Wang; Zin Z Khaing; Na Li; Brad Hall; Christine E Schmidt; Andrew D Ellington
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

5.  G-CSF protects motoneurons against axotomy-induced apoptotic death in neonatal mice.

Authors:  Alexandre Henriques; Claudia Pitzer; Luc Dupuis; Armin Schneider
Journal:  BMC Neurosci       Date:  2010-02-23       Impact factor: 3.288

6.  Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?

Authors:  Alexandre Henriques; Claudia Pitzer; Armin Schneider
Journal:  Front Neurosci       Date:  2010-06-11       Impact factor: 4.677

7.  In vivo evidence that TRAF4 is required for central nervous system myelin homeostasis.

Authors:  Sébastien Blaise; Marie Kneib; Adrien Rousseau; Frederic Gambino; Marie-Pierre Chenard; Nadia Messadeq; Martine Muckenstrum; Fabien Alpy; Catherine Tomasetto; Yann Humeau; Marie-Christine Rio
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

Review 8.  Nogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis.

Authors:  Felicia Yu Hsuan Teng; Bor Luen Tang
Journal:  J Cell Mol Med       Date:  2008-04-15       Impact factor: 5.310

9.  Deep proteomic evaluation of primary and cell line motoneuron disease models delineates major differences in neuronal characteristics.

Authors:  Daniel Hornburg; Carsten Drepper; Falk Butter; Felix Meissner; Michael Sendtner; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2014-09-05       Impact factor: 5.911

10.  Myelin-associated glycoprotein modulates apoptosis of motoneurons during early postnatal development via NgR/p75(NTR) receptor-mediated activation of RhoA signaling pathways.

Authors:  A Palandri; V R Salvador; J Wojnacki; A L Vivinetto; R L Schnaar; P H H Lopez
Journal:  Cell Death Dis       Date:  2015-09-03       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.